About

About Gelomics Gelomics is an Australian biotech company at the forefront of revolutionising drug development. Founded with a commitment to innovation and ethical research, Gelomics specialises in pioneering non-animal methodologies to accelerate the discovery of new drugs. Leveraging cutting-edge technology and a multidisciplinary approach, the company aims to provide more predictive and effective alternatives to traditional animal testing. Gelomics is dedicated to advancing human health by enabling scientists to grow human tissues in vitro, offering a groundbreaking platform for drug efficacy and safety assessment. With a focus on ethical practices and sustainability, Gelomics is setting a new standard in biotechnology, aiming to reshape the future of drug development globally.